Boards & Committees - I2C2



INTERNATIONAL & INTER-SOCIETY COORDINATION COMMITTEE (I2C2)
(Parentheses after name indicates year rotating off Committee)


PAST COMMITTEE MEETING:
Wednesday, April 5, 2017, 12:30 PM - 2:30 PM
in Gaslamp C of the Manchester Grand Hyatt Hotel, San Diego, CA, USA, during the ISHLT 37th Annual Meeting and Scientific Sessions



Strategies for Engagement and Collaboration With Other Medical/Scientific Societies ("Rules of Engagement") (PDF)



COMMITTEE COMPOSITION

  • The I2C2 shall consist of two Co-Chairs, one broadly responsible for international issues and one broadly responsible for inter-society issues, appointed by the Board of Directors and serving 4-year staggered terms.
  • The leader of each Scientific Council I2C2 Workforce shall serve on the Committee.
  • The Chairs of the Standards and Guidelines Committee, the Education Committee, the Finance Committee (or a Finance Committee representative), and the Registries and Databases Committee shall also serve on the Committee.
  • The Co-Chairs may appoint up to 4 additional ad hoc members as needed for renewable 2-year terms.
  • Ambassadors shall also be appointed to represent each interested country/geographic region. (see below)
COMMITTEE RESPONSIBILITIES

International

  • Identify opportunities to enhance clinical, regulatory  and scientific aspects of heart and lung transplantation, mechanical circulatory support and management of advanced heart and lung disease in nations and regions with limited experience in and infrastructure devoted to these diseases and issues.
  • Facilitate the provision of clinical and scientific expertise to governmental organizations (i.e., Ministries of Health, grant funding organizations) when requested by local medical/scientific organizations, academic institutions and/or hospitals; such assistance will be provided in the context of standards and guidelines that have been established and/or endorsed by the ISHLT.
  • Identify opportunities to foster exchanges of scientific information and collaboration, including in the development of translational and transnational research projects, the establishment of international registries or biobanks which extend discoveries at the bench to the clinical arena, and multicenter and multinational clinical trials.
  • Accomplish these aims while respecting the rules and political structures of local organizations with whom the ISHLT has engaged.
  • The I2C2 Workforce leader(s) from the relevant Scientific Council(s) will be responsible for working with their Scientific Council leadership to submit the resulting initiatives to the relevant Committee(s) who will review each submission and ultimately seek Board approval if warranted.
  • The implementation of the resulting initiatives will be through the relevant ISHLT Committees and Councils.
Inter-Society

  • Identify scientific/clinical areas and organizations where collaboration with those organizations with expertise in those areas would enhance the scientific, clinical, and educational missions of the ISHLT.
  • Facilitate the establishment of liaisons with such other organizations and facilitate communication and collaboration with these organizations.
  • Identify and facilitate opportunities for the development of joint sessions with other Societies at the ISHLT Annual Meeting.
  • Identify and facilitate opportunities for the development of joint sessions at the conferences of other medical/scientific societies.
  • Identify and facilitate opportunities for the development of joint standards and guidelines with other medical/scientific societies.
  • The I2C2 Workforce leader(s) from the relevant Scientific Council(s) will be responsible for working with their Scientific Council leadership to submit the resulting initiatives to the relevant Committee(s) who will review each submission and ultimately seek Board approval if warranted.
  • The relevant ISHLT Committees and Councils will be responsible for ultimate implementation of Board approved initiatives.
Ambassadors

Ambassadors are appointed after an individual contacts the Co-Chairs of I2C2 wishing to represent their country / geographic area.  Applicants will demonstrate a clear commitment to developing thoracic organ transplantation and end stage heart and lung failure therapies in their region.  Ambassadors will be appointed to serve a 3 year term which may be renewed by the I2C2 Committee Co-Chairs for an additional two years. Letters of interest are sought from all countries and geographic regions, especially those outside North America and Western Europe. Applicants must be members of ISHLT.

Ambassador Responsibilities

  • Formally represent their country and/or global region within the I2C2 committee.
  • Notify I2C2 of any issues of relevance to ISHLT arising within their global area.
  • Encourage their country/region’s governmental agency or institutions to submit data to the ISHLT Registries.
  • Liaise with national or regional Societies that share interests or members with ISHLT within their geographic zone to build partnerships and to facilitate educational and training opportunities.
  • Work with I2C2 on any geographic area-specific projects as needed.



  • Provide a brief annual report on regional transplant issues at the I2C2 Committee meeting each year.

COMMITTEE CHAIR:

Howard J. Eisen, MD, FAHA, FACC, FACP (2019)
Drexel University College of Medicine and Hahnemann University Hospital
Philadelphia, PA, USA





ADDITIONAL COMMITTEE MEMBERS:

BOARD OF DIRECTORS LIAISON
Maryl R. Johnson, MD (2018)
University of Wisconsin
Madison, WI, USA




STANDARDS & GUIDELINES COMMITTEE CHAIR
David O. Taylor, MD (2019)
Cleveland Clinic Foundation
Cleveland, OH, USA





DIRECTOR OF EDUCATIONAL AFFAIRS
Christopher H. Wigfield, MD, FRCS(C/Th) (2018)
Loyola University Medical Center
Maywood, Illinois, USA





FINANCE COMMITTEE CHAIR
Joseph Rogers, MD
Duke University Medical Center
Durham, NC, USA




THORACIC REGISTRY MEDICAL DIRECTOR
Josef Stehlik, MD, MPH
University of Utah
Salt Lake City, Utah, USA





COUNCIL WORKFORCE LEADERS:

Basic Science and Translational Research Council
TBD




Heart Failure and Transplantation Council
Alejandro Bertolotti, MD (2018)
Favaloro Foundation
Buenos Aires, ARGENTINA





Infectious Diseases Council
Fernanda Silveira, MD (2020)
University of Pittsburgh Medical Center
Pittsburgh, PA, USA





Junior Faculty and Trainee Council
Hirsch S. Mehta, MD (2019)
San Diego Cardiac Center
San Diego, CA, USA




Mechanical Circulatory Support Council
Sean P. Pinney, MD (2017)
Mount Sinai Medical Center
New York, New York, USA





Nursing, Health Sciences and Allied Health Council
Rasha Adam, RN (2019)
University of Minnesota Medical Center
Minneapolis, MN, USA





Pathology Council
Annalisa Angelini, MD (2018)
University of Padua
Padua, ITALY




Pediatric Transplantation Council
James D. St. Louis , MD (2018)
University of Missouri
Kansas City, MO, USA
816-302-8026




Pharmacy & Pharmacology Council
Douglas L. Jennings, PharmD (2018)
New York-Presbyterian Hospital/Columbia University
New York, NY, USA





Pulmonary Hypertension Council
Manreet Kanwar, MD (2019)
Allegheny General Hospital
Pittsburgh, PA, USA





Pulmonary Transplantation Council
Denis Hadjiliadis, MD (2019)
University of Pennsylvania
Philadephia, PA, USA





AD HOC MEMBERS:

Jacob Lavee, MD (2017)
Sheba Medical Center
Leviev Heart Center
Tel Hashomer, ISRAEL





Lori J. West, MD, DPhil (2017)
University of Alberta
Edmonton, Alberta, CANADA





GLOBAL AMBASSADORS:

ARGENTINA
Alejandro Bertolotti, MD (2017)
Favaloro Foundation University Hospital
Buenos Aires, ARGENTINA





BRAZIL
Paulo Pego Fernandes, MD, PhD (2017)
Universidade de São Paulo
Sao Paulo, BRAZIL





CHILE
Douglas Greig, MD (2017)
Universidad Católica de Chile
Santiago, CHILE






COLOMBIA
Adriana Torres Navas, MD (2017)
Fundacion Cardioinfantil
Bogota, COLOMBIA






FRANCE
Karine Nubret, MD (2017)
CHU de Bordeaux
Bordeaux, FRANCE






GREECE
Denis Hadjiliadis, MD (2017)
University of Pennsylvania
Philadelphia, PA, USA





INDIA (NEW DEHLI)
Sandeep G. Attawar, MD (2017)
Fortis Memorial Research Institute
Gurgaon, INDIA





KAZAKHSTAN
Yury Pya, MD (2017)
National Research Cardiac Surgery Center
Astana, KAZAKHSTAN





MALAYSIA
Ashari Yunus, MD (2017)
Institute Perubatan Respiratori
Kuala Lumpur, MALAYSIA




SAUDI ARABIA
Amal A AlOtaibi, MD (2017)
PSCC
Riyadh, SAUDI ARABIA





SINGAPORE
Cumara C. Sivathasan, MBBS FRCS (2017)
National Heart Centre
Singapore, SINGAPORE





SLOVENIA (LJUBLJANA)
Ivan Knezevic, MD (2017)
University Clinical Centre
Ljubljana, SLOVENIA





SWITZERLAND
Martin Schweiger, MD (2017)
Children's Hospital
Zurich, SWITZERLAND







COMMITTEE CHAIR:


Howard J. Eisen, MD, FAHA, FACC, FACP (2019)
Drexel University College of Medicine and Hahnemann University Hospital
Philadelphia, PA, USA
ADDITIONAL COMMITTEE MEMBERS:

BOARD OF DIRECTORS LIAISON
Maryl R. Johnson, MD (2018)
University of Wisconsin
Madison, WI, USA
STANDARDS & GUIDELINES COMMITTEE CHAIR
David O. Taylor, MD (2019)
Cleveland Clinic Foundation
Cleveland, OH, USA
DIRECTOR OF EDUCATIONAL AFFAIRS
Christopher H. Wigfield, MD, FRCS(C/Th) (2018)
Loyola University Medical Center
Maywood, Illinois, USA
FINANCE COMMITTEE CHAIR
Joseph Rogers, MD
Duke University Medical Center
Durham, NC, USA
THORACIC REGISTRY MEDICAL DIRECTOR
Josef Stehlik, MD, MPH
University of Utah
Salt Lake City, Utah, USA
COUNCIL WORKFORCE LEADERS:

Heart Failure and Transplantation Council
Alejandro Bertolotti, MD (2018)
Favaloro Foundation
Buenos Aires, ARGENTINA
Infectious Diseases Council
Fernanda Silveira, MD (2020)
University of Pittsburgh Medical Center
Pittsburgh, PA, USA
Junior Faculty and Trainee Council
Hirsch S. Mehta, MD (2019)
San Diego Cardiac Center
San Diego, CA, USA
Mechanical Circulatory Support Council
Sean P. Pinney, MD (2017)
Mount Sinai Medical Center
New York, New York, USA
Nursing, Health Sciences and Allied Health Council
Rasha Adam, RN (2019)
University of Minnesota Medical Center
Minneapolis, MN, USA
Pathology Council
Annalisa Angelini, MD (2018)
University of Padua
Padua, ITALY
Pediatric Transplantation Council
James D. St. Louis , MD (2018)
University of Missouri
Kansas City, MO, USA
Pharmacy & Pharmacology Council
Douglas L. Jennings, PharmD (2018)
New York-Presbyterian Hospital/Columbia University
New York, NY, USA
Pulmonary Hypertension Council
Manreet Kanwar, MD (2019)
Allegheny General Hospital
Pittsburgh, PA, USA
Pulmonary Transplantation Council
Denis Hadjiliadis, MD (2019)
University of Pennsylvania
Philadephia, PA, USA
AD HOC MEMBERS:

Jacob Lavee, MD (2017)
Sheba Medical Center
Leviev Heart Center
Tel Hashomer, ISRAEL
Lori J. West, MD, DPhil (2017)
University of Alberta
Edmonton, Alberta, CANADA

GLOBAL AMBASSADORS:

ARGENTINA
Alejandro Bertolotti, MD (2017)
Favaloro Foundation University Hospital
Buenos Aires, ARGENTINA
BRAZIL
Paulo Pego Fernandes, MD, PhD (2017)
Universidade de São Paulo
Sao Paulo, BRAZIL
CHILE
Douglas Greig, MD (2017)
Universidad Católica de Chile
Santiago, CHILE
COLOMBIA
Adriana Torres Navas, MD (2017)
Fundacion Cardioinfantil
Bogota, COLOMBIA
FRANCE
Karine Nubret, MD (2017)
CHU de Bordeaux
Bordeaux, FRANCE
GREECE
Denis Hadjiliadis, MD (2017)
University of Pennsylvania
Philadelphia, PA, USA
INDIA (NEW DEHLI)
Sandeep G. Attawar, MD (2017)
Fortis Memorial Research Institute
Gurgaon, INDIA
KAZAKHSTAN
Yury Pya, MD (2017)
National Research Cardiac Surgery Center
Astana, KAZAKHSTAN
MALAYSIA
Ashari Yunus, MD (2017)
Institute Perubatan Respiratori
Kuala Lumpur, MALAYSIA
SAUDI ARABIA
Amal A AlOtaibi, MD (2017)
PSCC
Riyadh, SAUDI ARABIA
SINGAPORE
Cumara C. Sivathasan, MBBS FRCS (2017)
National Heart Centre
Singapore, SINGAPORE
SLOVENIA (LJUBLJANA)
Ivan Knezevic, MD (2017)
University Clinical Centre
Ljubljana, SLOVENIA
SWITZERLAND
Martin Schweiger, MD (2017)
Children's Hospital
Zurich, SWITZERLAND
Text SizeIncrease Font SizeDecrease Font Size